Knocking down of host liver FMO3 in low density lipoprotein receptor (Ldlr)-deficient mice reduces the hepatic and plasma lipid levels, bile acid pool size, liver triglyceride secretion, ketone bodies, and glucose and insulin levels, resulting in the prevention of atherosclerosis [130]. This evidence concerns the gene LDLR and atherosclerosis.